Renovaro Biosciences's total assets for Q2 2024 were $111.34M, a decrease of -8.61% from the previous quarter. RENB total liabilities were $29.28M for the fiscal quarter, a 23.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.